TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Numerical Pain Rating Scale (After Performance Measures - 4SST, 5STS)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: AUC of the MTS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to UTI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of UTI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: recovery of motor function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: recovery of gait function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Percentage of Unscored Imaging Orders
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Cumulative Stress Index
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: self-reported subject energy levels
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Clinical signs and symptoms of inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Laboratory parameters of inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of Subjects With Freedom From Serious Adverse Events (SAE) Post-implant > 30 Days
Endpoint domain: Adverse events/effects
Primary endpoint: Subject's Average Effective Orifice Area (EOA) Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Size of created-fenestration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Investigator's Global Assessment Grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Percent Body Surface Area (BSA) Involved
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Average Chronic Pancreatitis Pain Intensity Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in global coronary flow reserve (CFR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Digital Ulcer healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: phase angle (PA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ALSFRS-r
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in executive function/working memory composite score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in episodic memory composite score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Cumulative rate of significant adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: All serious and unexpected adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Change of visual acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in frequency of usage of selection criteria for add-on therapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: 13C-urea breath test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Plasma TNF-α concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean Change From Baseline in Intraocular Pressure (IOP) at Day 14
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: bronchopulmonary dysplasia at 36 weeks of postmenstrual age
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Proportion of patients presenting a positive PET
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subject-reported Ocular Dryness Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fluorescein Nasal Region Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total adverse events rate
Endpoint domain: Adverse events/effects
Primary endpoint: Speech perception test battery and questionnaire scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Probing pocket Depth (PPD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Plasma HCV RNA Levels (log10 IU/mL) at Week 4
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Score Difference in Symptoms of Anxiety, Depression and Post-traumatic Stress Disorders
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Measure of successful encoding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weekly Mean Pain Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants readmitted to hospital
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Endocrine Symptoms Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Distress Level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: magnetic resonance imaging of knee
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: T-BG≥10
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Intracranial progression free survival
Endpoint domain: Mortality/survival
Primary endpoint: % of Patients in Whom a Sentinel Lymph Node is Identified
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Serum cortisol weighted mean (0-12h)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: local-regional control rates
Endpoint domain: Mortality/survival
Primary endpoint: safety of the treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Symptom report scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: thromboembolic events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Overall safety: type, grade and frequency of all adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: FPG after 14 days of treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of positive, negative and contaminated blood cultures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Genomic DNA Mutation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients in each patterns of dysarthria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Severe morbidity during hospitalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: c-IMT (Carotid Intima-Media Thickness)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of Participants With Clinical Laboratory Abnormalities at 1-Week After Vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants With Local Reactions by Maximum Severity Within 14 Days After Vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants With Systemic Events by Maximum Severity Within 14 Days After Vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: HCG stimulation test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Elicited Imitation Memory Task - Short Delay Memory Measure at 6 Months
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Elicited Imitation Memory Task - Short Delay Memory Measure at 9 Months
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Rate of Post-operative Infection
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Infections in Each Study Arm
Endpoint domain: Adverse events/effects
Primary endpoint: Total Bone Mineral Density (Tt.BMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Resting Blood Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Regional Recurrence-free Survival
Endpoint domain: Mortality/survival
Primary endpoint: Primary patency of device
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Actinic Keratoses Reduction Percent
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Rate of confirmed MR4
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in insulin sensitivity index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Diagnosis of acute myocarditis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of different indications for Endoscopic Ultrasound
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Reproducibility Coefficient (RDC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Local recurrence risk (LRR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Changes in HbA1C (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in fasting glucose concentration (mg/dl)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in 2-hr oral glucose tolerance (mg/dl)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Return-to-work rates within 6 months from hospital discharge
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Percentage of participants that maintained their employment at 12, 18, and 24 months of follow-up
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Percentage of Participants with accepted anatomical and functional recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delirium detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Healthy Sinus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Perioperative Anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Perioperative Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measurement of the full Visual Field
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Uteroovarian ligament length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in crestal osseous width
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Acute Procedural Success (APS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of Participants With AF Recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Adverse changes in liver ultrasound results
Endpoint domain: Adverse events/effects
Primary endpoint: Serum 25-hydroxyvitamin D levels in mothers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Levels of vitamin D in maternal milk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Area under the curve 0-336 (AUC336)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CD40 receptor occupancy on peripheral blood B cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Microbiological analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Gene expression profiling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hypoglycemia < 70 mg/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Participants With ≥1 Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Discontinuing Study Therapy Due to AE
Endpoint domain: Adverse events/effects
Primary endpoint: Overall success rate at 24 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Radiographic demonstration of spinal fusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: ODI improvement of at least 20%
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Beta-lactoglobulin immunoreactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence of Grade ≥ 2 oral mucositis
Endpoint domain: Adverse events/effects
Primary endpoint: Average inhaled corticosteroid treatment dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma amyloid-beta 42/40 ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the curve (AUC) of the blood test in predicting amyloid PET status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CR proportion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Short Form-36 Health Survey (SF-36v2®)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: modified Merle d'Aubigne and Postel scoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of prediction for hypertension criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neovascularization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum tolerated dose (MTD) of RGX-104
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall response rate associated with RGX-104 treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression-free survival associated with RGX-104 treatment
Endpoint domain: Mortality/survival
Primary endpoint: Peak Aerobic Fitness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of P. falciparum parasitemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Maximum dose determination
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency and causality of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Flexion Relaxation Response (FRR) ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Iodine uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Percentage of Patients With Complete Control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prognosis of patients with ST segment myocardial infarction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: IPSS Responders Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of WDVAX
Endpoint domain: Adverse events/effects
Primary endpoint: Biologic Activity of WDVAX
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: ST resolution >70% 60 minutes after PCI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Optic coherence tomography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vitreous haemorrhage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in functional mapping during motor task
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in hepatic gene expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity and specificity of MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Collagen deposition detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perception of Stress Questionnaire (PSQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Blood test parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in blood levels of ctDNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in blood levels of CA15-3
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in blood levels of TK-1 assays
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Glucose Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of patients completing two-thirds of their assigned treatment
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Postoperative blood loss (chest drainage)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Incidence of major bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: RBC Transfusion (volume and rate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of patients not requiring mechanical ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Time to mechanical ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Time to oxygen saturation normalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: lipid lowering effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Prevalence of malaria infection in children
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Entomological Inoculation Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: serum TSH level equal or greater than 30 uIU/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: 7-Days Urticaria Activity Score (UAS 7)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of early OHSS
Endpoint domain: Adverse events/effects
Primary endpoint: Severe-sepsis-induced organ dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Target Lesion Primary Patency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Change in self-reported dyspareunia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient's perception of COVID-19
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Medical use patterns
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of Hospital mortality
Endpoint domain: Mortality/survival
Primary endpoint: Myocardial deformation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Left ventricular twisting-untwisting
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Cosine Similarity of the Muscle Synergies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Percentage of patients maintaining LDL-C target goals
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Median Change from Baseline in Variant Allele Frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patellofemoral pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Mean Symptom Severity Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Karnofsky Performance Scale Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Inter/Intra observer correlation on cosmetic scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VEPs responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Exposure to risk of hypoglycemia
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline in CORE-OM
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: percent change from baseline in calculated LDL-C
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: change in acid exposure time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Changes in 18F-fluoride PET SUV - Tumor Bone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in 18F-fluoride PET SUV - Normal Bone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in 18F-fluoride Ki - Tumor Bone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in 18F-fluoride Ki - Normal Bone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection rate of early gastric cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: CDAI Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes